"Masoprocol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils.
Descriptor ID |
D009637
|
MeSH Number(s) |
D02.455.426.559.389.140.450.582 D02.455.426.559.389.657.166.550
|
Concept/Terms |
Masoprocol- Masoprocol
- (R*,S*)-4,4'-(2,3-Dimethylbutane-1,4-diyl)bispyrocatechol
- Nordihydroguaiaretic Acid
- Nordihydroguaiaretic Acid, (R*,S*)-Isomer
- Dihydronorguaiaretic Acid
- meso-Nordihydroguaiaretic Acid
- Acid, meso-Nordihydroguaiaretic
- meso Nordihydroguaiaretic Acid
|
Below are MeSH descriptors whose meaning is more general than "Masoprocol".
Below are MeSH descriptors whose meaning is more specific than "Masoprocol".
This graph shows the total number of publications written about "Masoprocol" by people in this website by year, and whether "Masoprocol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Masoprocol" by people in Profiles.
-
Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res. 2008 Oct 15; 14(20):6525-30.
-
Long-term elevation of cyclooxygenase-2, but not lipoxygenase, in regions synaptically distant from spreading depression. J Comp Neurol. 1996 Dec 16; 376(3):447-62.
-
Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA. 1995 Feb 08; 273(6):489-90.